glucagon like peptide 1 glp 1 receptor agonist Glucagon-like peptide-1 Video: Non-insulin injectable antidiabetic drugs
Description
These drugs mimic the effects of the naturally occurring GLP-1 hormone, which is produced in the small intestine and plays a crucial role in regulating insulin secretion, glucose homeostasis, and appetite.
2 GLP-1R monotherapy (e.g., semaglutide) is highly effective, but dual GLP-1R/GIPR agonists (e.g.,
In summary, GLP-1 drugs offer significant advantages for individuals with type 2 diabetes or weight management concerns
Why the first non-peptide oral GLP-1 is drawing serious attentionand where caution still applies
Obesity and Type 2 diabetes represent global health challenges, and there is an unmet need for long-lasting and effective pharmacotherapies
Clinicians should maintain heightened awareness for aspiration risk in perioperative settings
